Canada Life’s Invensense Inc INVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-7,228
| Closed | -$91K | – | 2576 |
|
|
2017
Q1 | $91K | Hold |
7,228
| – | – | ﹤0.01% | 2145 |
|
|
2016
Q4 | $93K | Hold |
7,228
| – | – | ﹤0.01% | 2142 |
|
|
2016
Q3 | $53K | Hold |
7,228
| – | – | ﹤0.01% | 2329 |
|
|
2016
Q2 | $44K | Hold |
7,228
| – | – | ﹤0.01% | 2343 |
|
|
2016
Q1 | $61K | Hold |
7,228
| – | – | ﹤0.01% | 2049 |
|
|
2015
Q4 | $74K | Hold |
7,228
| – | – | ﹤0.01% | 1964 |
|
|
2015
Q3 | $67K | Sell |
7,228
-3,382
| -32% | -$38K | ﹤0.01% | 1957 |
|
|
2015
Q2 | $162K | Buy |
10,610
+400
| +4% | +$6.04K | ﹤0.01% | 1506 |
|
|
2015
Q1 | $153K | Hold |
10,210
| – | – | ﹤0.01% | 1499 |
|
|
2014
Q4 | $165K | Buy |
10,210
+653
| +7% | +$11K | ﹤0.01% | 1416 |
|
|
2014
Q3 | $200K | Buy |
9,557
+4,719
| +98% | +$111K | ﹤0.01% | 1228 |
|
|
2014
Q2 | $103K | Buy |
4,838
+2,988
| +162% | +$61.1K | ﹤0.01% | 1564 |
|
|
2014
Q1 | $39K | Buy |
1,850
+715
| +63% | +$15K | ﹤0.01% | 1930 |
|
|
2013
Q4 | $20K | Hold |
1,135
| – | – | ﹤0.01% | 2135 |
|
|
2013
Q3 | $20K | Buy |
+1,135
| New | +$19.2K | ﹤0.01% | 1082 |
|
Canada Life's INVN Position: Q2 2017 in Review
Canada Life sold out of Invensense Inc (INVN) in Q2 2017, closing a stake of 7,228 shares — an estimated $91K sold.
Canada Life first reported a position in INVN in Q3 2013 and held it in 15 quarters. The position peaked at $200K in Q3 2014. 0 funds tracked by Wall St. Rank hold INVN as of Q2 2017.
- Canada Life reported no remaining Invensense Inc position as of Q2 2017 after selling out during the quarter.
- Canada Life sold 7,228 Invensense Inc shares in Q2 2017, an estimated $91K.
- Canada Life first reported a position in Invensense Inc in Q3 2013 and held it in 15 quarters.
- Canada Life's Invensense Inc position peaked at $200K in Q3 2014.
- 0 funds tracked by Wall St. Rank held Invensense Inc as of Q2 2017.
Based on Canada Life's 13F filing for Q2 2017, filed 27 Jul 2017.